United States Digital Biomarkers Market Insight
Published: 27 June 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The United States Digital Biomarkers Market is projected to grow at a CAGR of around 16.8%, driven by the increasing adoption of wearable health technologies and personalized healthcare solutions.
United States Digital Biomarkers Market Forecasts to 2035
- The United States Digital Biomarkers Market size was estimated at approximately USD 1,180 Million in 2025.
- The market is expected to grow at a CAGR of around 16.8% from 2025 to 2035.
- The United States Digital Biomarkers Market is projected to reach approximately USD 5,580 Million by 2035.
Notable Insight the United States Digital Biomarkers Market
- Based on biomarker type, Physiological Biomarkers and Behavioral Biomarkers account for nearly 66% of market revenue in 2025, supported by their widespread use in continuous health monitoring and disease management.
- Based on application, Cardiovascular Disease Monitoring and Neurological Disorder Management represent approximately 62% of total market demand, driven by increasing adoption of wearable sensors, mobile health applications, and AI-enabled diagnostics.
- The market is increasingly influenced by artificial intelligence, machine learning algorithms, and connected wearable devices, with these technologies accounting for more than 58% of newly launched digital biomarker solutions in 2025.
Download the eBook (ToC)
- Growing investments in digital therapeutics, remote patient monitoring, and precision medicine are supporting market expansion, with AI-driven digital biomarker platforms accounting for nearly 47% of new digital health investments in 2025.
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Semiconductors & Optoelectronics
Decisions Advisors offers intelligent market research which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Remote Sensing Infrared Light Emitting Diode Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Digital Biomarkers Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies United States Digital Biomarkers Market
- Biofourmis Inc.
- Evidation Health, Inc.
- AliveCor, Inc.
- Fitbit (Google)
- Empatica Inc.
- ActiGraph LLC
- Koneksa Health
- Philips Healthcare
- Medable Inc.
- Verily Life Sciences LLC
Recent Developments:
- In March 2025, Biofourmis Inc. expanded its AI-powered digital biomarker platform to enhance remote patient monitoring for chronic disease management.
- In February 2025, Verily Life Sciences LLC introduced advanced digital biomarker analytics integrating wearable sensor data with AI algorithms to improve personalized healthcare and clinical research.
Market Segmentation:
United States Digital Biomarkers Market, By Biomarker Type
- Physiological Biomarkers
- Behavioral Biomarker
- Molecular Digital Biomarkers
- Imaging Digital Biomarkers
United States Digital Biomarkers Market, By Application
- Cardiovascular Disease Monitoring
- Neurological Disorders
- Respiratory Disease Monitoring
- Diabetes Management
- Clinical Trials
United States Digital Biomarkers Market, By End User
- Hospitals & Healthcare Providers
- Pharmaceutical & Biotechnology Companies
- Research Organizations
- Home Healthcare
- Academic Institutions
Expert Views:
The United States Digital Biomarkers Market is expected to witness robust growth through 2035, supported by increasing adoption of digital health technologies, expanding use of wearable medical devices, and growing demand for continuous patient monitoring. Advancements in artificial intelligence, cloud-based analytics, remote healthcare platforms, and precision medicine are anticipated to strengthen long-term market growth. Furthermore, increasing investments in decentralized clinical trials, personalized healthcare, and digital therapeutics are expected to create significant opportunities for digital health companies, healthcare providers, pharmaceutical firms, and technology developers across the United States.
Author: Govind and Krishna By Decisions Advisors and Consulting